A systematic review suggests that inflammation can alter drug metabolism in children, with effects differing by pathway and age.
What the source reports
Twenty-seven studies and case reports were included. The review discusses reduced midazolam clearance in critically ill children as one example of a clinically relevant drug-disease interaction. Effects across CYP pathways were not uniform, and activity could change again as illness resolved.
Limits and uncertainty
The evidence combined different diseases, ages, designs, and drugs. The search was limited to one database and published material. A percentage clearance change from one setting cannot be applied as a fixed adjustment to every child or illness.
Implications for forensic review
For a pediatric sedation opinion, consider evolving disease alongside dose and co-medications. A pharmacokinetic expectation drawn from healthy patients may not fit acute inflammation. The paper supports investigating that possibility, but it does not establish the clearance or functional effects of a specific patient without appropriate clinical evidence.
Source and related reading
Source reviewed: Impact of Inflammation on Cytochromes P450 Activity in Pediatrics A Systematic Review (PMC8613112). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: A Febrile-Seizure Survey Found No Home Diazepam or Buccal Midazolam Use; Midazolam–Ketamine Pediatric Colonoscopy Had More Recovery Events Than Propofol–Fentanyl.
Leave a Reply